Vaithilingam V. Banurekha

Type 2 Diabetes Mellitus Coincident with Pulmonary Tuberculosis Is Associated with Heightened Systemic Type 1, Type 17, and Other Proinflammatory Cytokines

Nathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V. Banurekha et al. · Annals of the American Thoracic Society · 2013 · 122 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Expansion of Pathogen-Specific T-Helper 1 and T-Helper 17 Cells in Pulmonary Tuberculosis With Coincident Type 2 Diabetes Mellitus

Nathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V. Banurekha et al. · The Journal of Infectious Diseases · 2013 · 111 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis

Nathella Pavan Kumar, Kadar Moideen, Vaithilingam V. Banurekha et al. · Open Forum Infectious Diseases · 2019 · 106 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

M S Jawahar, Vaithilingam V. Banurekha, Chinnampedu N. Paramasivan et al. · PLoS ONE · 2013 · 97 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Type 2 diabetes mellitus is associated with altered <scp>CD</scp>8⁺ T and natural killer cell function in pulmonary tuberculosis

Nathella Pavan Kumar, Rathinam Sridhar, Dina Nair et al. · Immunology · 2014 · 94 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16